Indinavir

Generic name: Pronounced as (in din' a veer)
Brand names
  • Crixivan®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 05/18/2018

Indinavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Indinavir is in a class of medications called protease inhibitors. It works by decreasing the amount of HIV in the blood. Although indinavir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting the HIV virus to other people.

Indinavir comes as a capsule to take by mouth. It is usually taken every 8 hours (three times a day). Take indinavir at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take indinavir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Take indinavir on an empty stomach, 1 hour before meals or 2 hours after meals, with water, skim or nonfat milk, juice, coffee, or tea. However, if indinavir upsets your stomach, it may be taken with a light meal, such as dry toast or cornflakes with skim or nonfat milk. Talk to your doctor or pharmacist about what foods may be taken with indinavir.

Do not crush or chew the capsule, but it may be opened and mixed with fruit puree (such as banana).

Continue to take indinavir even if you feel well. Do not stop taking indinavir without talking to your doctor.

Your doctor may need to interrupt your treatment if you experience certain side effects. Be sure to tell your doctor how you are feeling during your treatment with indinavir.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

Indinavir is also used sometimes in combination with other medications to treat healthcare workers and other individuals exposed to HIV infection after accidental contact with HIV-contaminated blood, tissues, or other body fluids. Talk to your doctor about the possible risks of using this drug for your condition.

Before taking indinavir,

  • tell your doctor and pharmacist if you are allergic to indinavir, any other medications, or any of the ingredients in indinavir capsules. Ask your pharmacist for a list of the ingredients.

  • tell your doctor if you are taking any of the following medications: alfuzosin (Uroxatral); alprazolam (Xanax); amiodarone (Nexterone, Pacerone); cisapride (Propulsid) (not available in the U.S.); ergot-type medications such as dihydroergotamine (D.H.E. 45, Migranal), ergonovine (Ergotrate), ergotamine (Ergomar, in Cafergot, in Migergot), and methylergonovine (Methergine); lovastatin (Altoprev, Mevacor); lurasidone (Latuda); midazolam (Versed) by mouth; pimozide (Orap); sildenafil (only Revatio brand used for lung disease); simvastatin (Zocor, in Vytorin); or triazolam (Halcion). Your doctor will probably tell you not to take indinavir.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: bosentan (Tracleer); calcium-channel blockers such as amlodipine (Norvasc, in Amturnide, in Tekamlo), felodipine, nicardipine, and nifedipine (Adalat, Afeditab, Procardia); carbamazepine (Carbatrol, Epitol, Equetro, Tegretol, others); cholesterol-lowering medications (statins) such as atorvastatin (Lipitor, in Caduet) and rosuvastatin (Crestor); clarithromycin (Biaxin, in PrevPac); colchicine (Colcrys, Mitigare, in Col-Probenecid); dexamethasone; fluconazole (Diflucan); fluticasone (Flonase, Flovent, in Advair, in Dymista); itraconazole (Onmel, Sporanox); ketoconazole (Extina, Nizoral, Xolegel); other medications for HIV including atazanavir (Reyataz, in Evotaz), delavirdine (Rescriptor), efavirenz (Sustiva, in Atripla), nelfinavir (Viracept), nevirapine (Viramune), ritonavir (Norvir, in Kaletra, in Viekira Pak), and saquinavir (Invirase); medications for irregular heartbeat such as lidocaine (Glydo, Xylocaine) and quinidine (in Nuedexta); medications that suppress the immune system such as cyclosporine (Gengraf, Neoral, Sandimmune), sirolimus (Rapamune), and tacrolimus (Astagraf XL, Envarsus XR, Prograf); midazolam (Versed) by injection; certain phosphodiesterase inhibitors (PDE-5 inhibitors) used for erectile dysfunction such as sildenafil (Viagra), tadalafil (Adcirca, Cialis), and vardenafil (Levitra, in Staxyn); phenobarbital; phenytoin (Dilantin, Phenytek); quetiapine (Seroquel); rifabutin (Mycobutin); rifampin (Rifadin, Rimactane, in Rifamate, in Rifater); salmeterol (Serevent, in Advair); trazodone; and venlafaxine (Effexor). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with indinavir, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor what herbal products you are taking, especially St. John's wort.

  • if you are taking didanosine (Videx), take it at least one hour before or after indinavir.

  • tell your doctor if you have or have ever had hemophilia (bleeding disorder in which the blood does not clot properly), diabetes, or kidney or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking indinavir, call your doctor. You should not breastfeed if you are infected with HIV or if you are taking indinavir.

  • you should know that your body fat may increase or move to different areas of your body such as your breasts, upper back, neck, chest, and stomach area. Loss of fat from the legs, arms, and face can also happen.

  • you should know that you may experience hyperglycemia (increases in your blood sugar) while you are taking this medication, even if you do not already have diabetes. Tell your doctor immediately if you have any of the following symptoms while you are taking indinavir: extreme thirst, frequent urination, extreme hunger, blurred vision, or weakness. It is very important to call your doctor as soon as you have any of these symptoms, because high blood sugar that is not treated can cause a serious condition called ketoacidosis. Ketoacidosis may become life-threatening if it is not treated at an early stage. Symptoms of ketoacidosis include dry mouth, nausea and vomiting, shortness of breath, breath that smells fruity, and decreased consciousness.

  • you should know that while you are taking medications to treat HIV infection, your immune system may get stronger and begin to fight other infections that were already in your body. This may cause you to develop symptoms of those infections. If you have new or worsening symptoms at any time during your treatment with indinavir, be sure to tell your doctor.

Drink at least 48 ounces (1.5 liters), which is approximately six 8-ounce (240-milliliter) glasses, of water or other liquids every 24 hours.

Talk to your doctor about eating grapefruit and drinking grapefruit juice while taking this medication.

If you miss a dose by less than 2 hours, take the missed dose as soon as you remember it. However, if you miss a dose by more than 2 hours, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Indinavir may cause side effects. Tell your doctor if this symptom is severe or does not go away:

    • change in sense of taste

  • Indinavir may cause side effects. Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment:

    • rash

    • hives

    • itching

    • peeling or blistering skin

    • back pain

    • pain in the side of your body

    • middle to lower stomach pain

    • blood in urine

    • muscle pain or weakness

    • nausea

    • excessive tiredness

    • unusual bleeding or bruising

    • loss of appetite

    • pain in the upper right part of your stomach

    • flu-like symptoms

    • dark yellow or brown urine

    • yellowing of the skin or eyes

    • shortness of breath

    • fast heartbeat

    • confusion

    • dizziness

    • headache

    • paleness

  • Indinavir may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. A desiccant (drying agent) is included with your capsules; keep this in your medicine bottle at all times. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • pain in the side of your body

  • blood in urine

  • nausea

  • vomiting

  • diarrhea

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your response to indinavir.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Repaglinide Repaglinide Repaglinide may decrease the excretion rate of Indinavir which could result in a higher serum level.
Montelukast Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Montelukast.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Indinavir.
Leflunomide Leflunomide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Leflunomide.
Delavirdine Delavirdine The serum concentration of Indinavir can be increased when it is combined with Delavirdine.
Nevirapine Nevirapine The serum concentration of Indinavir can be decreased when it is combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Indinavir.
Alendronate Alendronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Alendronic acid.
Calcium Carbonate Calcium Carbonate Calcium carbonate can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Indinavir.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Indinavir.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Indinavir can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The excretion of Conjugated estrogens can be decreased when combined with Indinavir.
Fenofibrate Fenofibrate Indinavir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Indinavir is combined with Guanfacine.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide Magnesium Oxide Magnesium oxide can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Indinavir.
Mycophenolate Mycophenolate The metabolism of Mycophenolic acid can be decreased when combined with Indinavir.
Nafarelin Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Nafarelin.
Paregoric Paregoric The metabolism of Morphine can be decreased when combined with Indinavir.
Ranitidine Ranitidine Ranitidine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Reserpine Reserpine Reserpine may decrease the excretion rate of Indinavir which could result in a higher serum level.
Sumatriptan Sumatriptan The excretion of Sumatriptan can be decreased when combined with Indinavir.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Indinavir.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be increased when combined with Indinavir.
Famotidine Injection Famotidine Injection Famotidine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluconazole Injection Fluconazole Injection The metabolism of Indinavir can be decreased when combined with Fluconazole.
Metoclopramide Injection Metoclopramide Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Indinavir.
Morphine Injection Morphine Injection The metabolism of Morphine can be decreased when combined with Indinavir.
Pamidronate Injection Pamidronate Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Pamidronic acid.
Zidovudine Injection Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Zidovudine.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Indinavir.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Indinavir.
Torsemide Torsemide The excretion of Torasemide can be decreased when combined with Indinavir.
Olanzapine Olanzapine Olanzapine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Eprosartan Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Eprosartan.
Oxcarbazepine Oxcarbazepine The metabolism of Indinavir can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole Pantoprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Risedronate Risedronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Risedronic acid.
Telmisartan Telmisartan Indinavir may decrease the excretion rate of Telmisartan which could result in a higher serum level.
Zaleplon Zaleplon The metabolism of Zaleplon can be decreased when combined with Indinavir.
Anakinra Anakinra The metabolism of Indinavir can be increased when combined with Anakinra.
Etanercept Injection Etanercept Injection The metabolism of Indinavir can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Indinavir can be increased when combined with Modafinil.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Indinavir.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Indinavir.
Epinephrine Injection Epinephrine Injection The risk or severity of adverse effects can be increased when Indinavir is combined with Epinephrine.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Indinavir.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Indinavir which could result in a higher serum level.
Zonisamide Zonisamide The metabolism of Zonisamide can be decreased when combined with Indinavir.
Adalimumab Injection Adalimumab Injection The metabolism of Indinavir can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Indinavir.
Ezetimibe Ezetimibe Indinavir may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Atazanavir Atazanavir The risk or severity of hyperbilirubinemia can be increased when Atazanavir is combined with Indinavir.
Mefloquine Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Mefloquine.
Rosuvastatin Rosuvastatin Indinavir may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Vardenafil Vardenafil The serum concentration of Vardenafil can be increased when it is combined with Indinavir.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Indinavir.
Aprepitant Aprepitant The metabolism of Indinavir can be decreased when combined with Aprepitant.
Tadalafil Tadalafil The metabolism of Tadalafil can be decreased when combined with Indinavir.
Progesterone Progesterone Indinavir may decrease the excretion rate of Progesterone which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be decreased when combined with Indinavir.
Infliximab Injection Infliximab Injection The metabolism of Indinavir can be increased when combined with Infliximab.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Indinavir.
Tinidazole Tinidazole Indinavir may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The serum concentration of Bosentan can be increased when it is combined with Indinavir.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Indinavir.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Indinavir.
Ganciclovir Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Ganciclovir.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Indinavir.
Voriconazole Voriconazole The metabolism of Indinavir can be decreased when combined with Voriconazole.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be decreased when used in combination with Indinavir.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be decreased when used in combination with Indinavir.
Ibandronate Ibandronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Ibandronate.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Indinavir.
Deferasirox Deferasirox The metabolism of Deferasirox can be decreased when combined with Indinavir.
Tipranavir Tipranavir Tipranavir may decrease the excretion rate of Indinavir which could result in a higher serum level.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Indinavir.
Ranolazine Ranolazine Indinavir may decrease the excretion rate of Ranolazine which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Indinavir can be increased when combined with Abatacept.
Imatinib Imatinib The metabolism of Indinavir can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Indinavir.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Indinavir.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Indinavir.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Indinavir.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The therapeutic efficacy of Varicella Zoster Vaccine (Live/attenuated) can be decreased when used in combination with Indinavir.
Fulvestrant Injection Fulvestrant Injection The metabolism of Fulvestrant can be decreased when combined with Indinavir.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Indinavir.
Darunavir Darunavir The serum concentration of Darunavir can be increased when it is combined with Indinavir.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Indinavir.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Indinavir.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Indinavir.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Indinavir.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Indinavir.
Armodafinil Armodafinil The metabolism of Indinavir can be increased when combined with Armodafinil.
Ivermectin Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Ivermectin.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Indinavir.
Raltegravir Raltegravir The metabolism of Raltegravir can be decreased when combined with Indinavir.
Budesonide Budesonide The metabolism of Indinavir can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Indinavir can be decreased when combined with Chloramphenicol.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Indinavir.
Certolizumab Injection Certolizumab Injection The metabolism of Indinavir can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The risk or severity of neutropenia can be increased when Irinotecan is combined with Indinavir.
Daptomycin Injection Daptomycin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Indinavir.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Indinavir.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Indinavir.
Naltrexone Injection Naltrexone Injection The metabolism of Naltrexone can be decreased when combined with Indinavir.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Indinavir.
Dexlansoprazole Dexlansoprazole Dexlansoprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Indinavir.
Dronedarone Dronedarone The metabolism of Indinavir can be decreased when combined with Dronedarone.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Indinavir.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Indinavir.
Golimumab Injection Golimumab Injection The metabolism of Indinavir can be increased when combined with Golimumab.
Asenapine Asenapine Asenapine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pitavastatin Pitavastatin The serum concentration of Pitavastatin can be decreased when it is combined with Indinavir.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be decreased when combined with Indinavir.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be decreased when used in combination with Indinavir.
Tocilizumab Injection Tocilizumab Injection The metabolism of Indinavir can be increased when combined with Tocilizumab.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Indinavir.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Indinavir.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be decreased when used in combination with Indinavir.
Rilpivirine Rilpivirine The serum concentration of Rilpivirine can be increased when it is combined with Indinavir.
Telaprevir Telaprevir The excretion of Glecaprevir can be decreased when combined with Indinavir.
Cyclophosphamide Injection Cyclophosphamide Injection The serum concentration of the active metabolites of Cyclophosphamide can be increased when Cyclophosphamide is used in combination with Indinavir.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Indinavir.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Indinavir.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Indinavir.
Crizotinib Crizotinib The metabolism of Indinavir can be decreased when combined with Crizotinib.
Naloxone Injection Naloxone Injection The metabolism of Naloxone can be decreased when combined with Indinavir.
Ambrisentan Ambrisentan The excretion of Ambrisentan can be decreased when combined with Indinavir.
Ezogabine Ezogabine The metabolism of Tiagabine can be decreased when combined with Indinavir.
Iloprost Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Indinavir.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Indinavir.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Indinavir.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be decreased when used in combination with Indinavir.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Indinavir.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Indinavir.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Indinavir.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Indinavir.
Dolutegravir Dolutegravir The metabolism of Dolutegravir can be decreased when combined with Indinavir.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Indinavir.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Indinavir.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Indinavir.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Indinavir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Indinavir.
Apremilast Apremilast The metabolism of Indinavir can be increased when combined with Apremilast.
Siltuximab Injection Siltuximab Injection The metabolism of Indinavir can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be decreased when used in combination with Indinavir.
Eslicarbazepine Eslicarbazepine The metabolism of Eslicarbazepine can be decreased when combined with Indinavir.
Belinostat Injection Belinostat Injection The metabolism of Belinostat can be decreased when combined with Indinavir.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Indinavir.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Indinavir.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Indinavir.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Indinavir.
Caspofungin Injection Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Indinavir.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Indinavir.
Secukinumab Injection Secukinumab Injection The metabolism of Indinavir can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be decreased when combined with Indinavir.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be decreased when used in combination with Indinavir.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Indinavir which could result in a higher serum level.
Haloperidol Injection Haloperidol Injection The serum concentration of Indinavir can be increased when it is combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Indinavir which could result in a lower serum level and potentially a reduction in efficacy.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Indinavir.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Indinavir.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Indinavir.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Indinavir.
Cobimetinib Cobimetinib The excretion of Cobimetinib can be decreased when combined with Indinavir.
Trabectedin Injection Trabectedin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Trabectedin.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Dexamethasone can be increased when combined with Indinavir.
Cobicistat Cobicistat The metabolism of Indinavir can be decreased when combined with Cobicistat.
Selexipag Selexipag The excretion of Selexipag can be decreased when combined with Indinavir.
Furosemide Injection Furosemide Injection The metabolism of Furosemide can be decreased when combined with Indinavir.
Rucaparib Rucaparib The metabolism of Indinavir can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Indinavir.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Indinavir.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Indinavir.
Deflazacort Deflazacort The metabolism of Indinavir can be increased when combined with Deflazacort.
Safinamide Safinamide The metabolism of Indinavir can be decreased when combined with Safinamide.
Midostaurin Midostaurin The metabolism of Indinavir can be increased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Indinavir.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Indinavir.
Delafloxacin Delafloxacin The metabolism of Delafloxacin can be decreased when combined with Indinavir.
Acalabrutinib Acalabrutinib The metabolism of Indinavir can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Indinavir.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be decreased when used in combination with Indinavir.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Indinavir.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Indinavir.
Penicillamine Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Penicillamine.
Sodium Zirconium Cyclosilicate Sodium Zirconium Cyclosilicate Sodium zirconium cyclosilicate can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Indinavir.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Indinavir.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Indinavir.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Indinavir.
Cannabidiol Cannabidiol The metabolism of Indinavir can be decreased when combined with Cannabidiol.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Indinavir.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Indinavir.
Prucalopride Prucalopride The metabolism of Indinavir can be decreased when combined with Prucalopride.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Indinavir can be increased when combined with Emapalumab.
Acyclovir Ophthalmic Acyclovir Ophthalmic The risk or severity of adverse effects can be increased when Indinavir is combined with Acyclovir.
Esomeprazole Injection Esomeprazole Injection Esomeprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cladribine Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Cladribine.
Darolutamide Darolutamide The metabolism of Darolutamide can be decreased when combined with Indinavir.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Indinavir.
Pitolisant Pitolisant The serum concentration of Pitolisant can be decreased when it is combined with Indinavir.
Phenytoin Injection Phenytoin Injection The serum concentration of Phenytoin can be decreased when it is combined with Indinavir.
Fosphenytoin Injection Fosphenytoin Injection The serum concentration of Indinavir can be decreased when it is combined with Fosphenytoin.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Indinavir.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Indinavir.
Cenobamate Cenobamate The serum concentration of Indinavir can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Indinavir.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Indinavir.
Remdesivir Injection Remdesivir Injection The excretion of Remdesivir can be decreased when combined with Indinavir.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The serum concentration of Sacituzumab govitecan can be increased when it is combined with Indinavir.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be increased when it is combined with Indinavir.
Capmatinib Capmatinib The serum concentration of Capmatinib can be increased when it is combined with Indinavir.
Lemborexant Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Indinavir.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Indinavir may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Indinavir which could result in a higher serum level.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Indinavir can be decreased when it is combined with Satralizumab.
Indomethacin Indomethacin The metabolism of Indomethacin can be decreased when combined with Indinavir.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Indinavir.
Trazodone Trazodone The metabolism of Trazodone can be decreased when combined with Indinavir.
Isotretinoin Isotretinoin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Isotretinoin.
Sodium Bicarbonate Sodium Bicarbonate Sodium bicarbonate can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Phenobarbital Phenobarbital The metabolism of Indinavir can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Methotrexate.
Chlorpromazine Chlorpromazine Chlorpromazine may decrease the excretion rate of Indinavir which could result in a higher serum level.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Indinavir.
Amantadine Amantadine The risk or severity of adverse effects can be increased when Indinavir is combined with Amantadine.
Codeine Codeine The risk or severity of adverse effects can be increased when Indinavir is combined with Codeine.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Indinavir.
Phenelzine Phenelzine The metabolism of Indinavir can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Procarbazine.
Minocycline Minocycline The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Minocycline.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Indinavir.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Indinavir.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Indinavir.
Methadone Methadone The metabolism of Methadone can be decreased when combined with Indinavir.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Indinavir.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Indinavir.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be decreased when combined with Indinavir.
Doxorubicin Doxorubicin Indinavir may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Indinavir is combined with Cytarabine.
Carbamazepine Carbamazepine The serum concentration of Carbamazepine can be decreased when it is combined with Indinavir.
Methyldopa Methyldopa The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Methyldopa.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Indinavir.
Prazosin Prazosin The risk or severity of adverse effects can be increased when Indinavir is combined with Prazosin.
Cimetidine Cimetidine Cimetidine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Indinavir.
Promethazine Promethazine Promethazine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Daunorubicin Daunorubicin Daunorubicin may decrease the excretion rate of Indinavir which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Indinavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin Indinavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Chloroquine.
Quinine Quinine The therapeutic efficacy of Quinine can be decreased when used in combination with Indinavir.
Sulfinpyrazone Sulfinpyrazone Indinavir may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Indinavir.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Indinavir.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Indinavir.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Indinavir.
Procainamide Procainamide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Procainamide.
Isoniazid Isoniazid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Isoniazid.
Rifampin Rifampin The metabolism of Indinavir can be increased when combined with Rifampicin.
Disopyramide Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Indinavir.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Indinavir.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Indinavir.
Levothyroxine Levothyroxine The metabolism of Levothyroxine can be decreased when combined with Indinavir.
Liothyronine Liothyronine The metabolism of Liothyronine can be decreased when combined with Indinavir.
Propylthiouracil Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Indinavir.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Indinavir.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Indinavir.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Indinavir.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Indinavir.
Niacin Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Niacin.
Baclofen Baclofen The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Indinavir.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Indinavir.
Disulfiram Disulfiram Indinavir may decrease the excretion rate of Disulfiram which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Indinavir.
Minoxidil Minoxidil The metabolism of Minoxidil can be decreased when combined with Indinavir.
Spironolactone Spironolactone Indinavir may decrease the excretion rate of Spironolactone which could result in a higher serum level.
Amphotericin B Injection Amphotericin B Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Amphotericin B.
Colchicine Colchicine The serum concentration of Colchicine can be increased when it is combined with Indinavir.
Cefaclor Cefaclor Indinavir may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Indinavir.
Ketoconazole Ketoconazole The metabolism of Indinavir can be decreased when combined with Ketoconazole.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Indinavir.
Captopril Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Captopril.
Dipyridamole Dipyridamole Indinavir may decrease the excretion rate of Dipyridamole which could result in a higher serum level.
Vinblastine Vinblastine Vinblastine may decrease the excretion rate of Indinavir which could result in a higher serum level.
Hydroxyzine Hydroxyzine The metabolism of Hydroxyzine can be decreased when combined with Indinavir.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Indinavir.
Triazolam Triazolam The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Triazolam.
Trimethoprim Trimethoprim The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Trimethoprim.
Diltiazem Diltiazem The metabolism of Indinavir can be decreased when combined with Diltiazem.
Nifedipine Nifedipine Indinavir may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Verapamil Verapamil The metabolism of Indinavir can be decreased when combined with Verapamil.
Atenolol Atenolol Indinavir may decrease the excretion rate of Atenolol which could result in a higher serum level.
Bumetanide Bumetanide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Bumetanide.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Indinavir.
Glyburide Glyburide Indinavir may decrease the excretion rate of Glyburide which could result in a higher serum level.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Indinavir.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be decreased when used in combination with Indinavir.
Labetalol Labetalol The metabolism of Labetalol can be decreased when combined with Indinavir.
Leuprolide Injection Leuprolide Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Indinavir.
Gemfibrozil Gemfibrozil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Gemfibrozil.
Ketoprofen Ketoprofen The metabolism of Ketoprofen can be decreased when combined with Indinavir.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Indinavir.
Enalapril Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Enalapril.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Indinavir.
Amiodarone Amiodarone The serum concentration of Amiodarone can be increased when it is combined with Indinavir.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Indinavir.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Indinavir.
Ciprofloxacin Ciprofloxacin The metabolism of Indinavir can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac Indinavir may decrease the excretion rate of Diclofenac which could result in a higher serum level.
Ofloxacin Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Ofloxacin.
Didanosine Didanosine Didanosine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clarithromycin Clarithromycin The serum concentration of Clarithromycin can be increased when it is combined with Indinavir.
Felodipine Felodipine Indinavir may decrease the excretion rate of Felodipine which could result in a higher serum level.
Pravastatin Pravastatin Indinavir may decrease the excretion rate of Pravastatin which could result in a higher serum level.
Simvastatin Simvastatin Indinavir may decrease the excretion rate of Simvastatin which could result in a higher serum level.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Indinavir.
Itraconazole Itraconazole The metabolism of Indinavir can be decreased when combined with Itraconazole.
Atovaquone Atovaquone Atovaquone can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rifabutin Rifabutin The serum concentration of the active metabolites of Rifabutin can be increased when Rifabutin is used in combination with Indinavir.
Isradipine Isradipine Indinavir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Omeprazole Omeprazole Omeprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cisapride Cisapride The serum concentration of Cisapride can be increased when it is combined with Indinavir.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Indinavir.
Venlafaxine Venlafaxine The serum concentration of Indinavir can be decreased when it is combined with Venlafaxine.
Nizatidine Nizatidine Nizatidine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Stavudine Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Stavudine.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Indinavir which could result in a higher serum level.
Nefazodone Nefazodone Indinavir may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Lamotrigine Lamotrigine The metabolism of Lamotrigine can be decreased when combined with Indinavir.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Indinavir.
Tramadol Tramadol The metabolism of Indinavir can be decreased when combined with Tramadol.
Lansoprazole Lansoprazole Lansoprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Indinavir.
Nicardipine Nicardipine Indinavir may decrease the excretion rate of Nicardipine which could result in a higher serum level.
Saquinavir Saquinavir The metabolism of Indinavir can be decreased when combined with Saquinavir.
Metformin Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Indinavir.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be decreased when combined with Indinavir.
Lamivudine Lamivudine The risk or severity of adverse effects can be increased when Indinavir is combined with Lamivudine.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Indinavir.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Indinavir.
Ritonavir Ritonavir The serum concentration of Indinavir can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Indinavir.
Valsartan Valsartan The excretion of Valsartan can be decreased when combined with Indinavir.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Indinavir.
Pramipexole Pramipexole The risk or severity of adverse effects can be increased when Indinavir is combined with Pramipexole.
Nelfinavir Nelfinavir The metabolism of Indinavir can be decreased when combined with Nelfinavir.
Fexofenadine Fexofenadine The excretion of Fexofenadine can be decreased when combined with Indinavir.
Loratadine Loratadine Indinavir may decrease the excretion rate of Loratadine which could result in a higher serum level.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Indinavir.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Indinavir.
Letrozole Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Letrozole.
Raloxifene Raloxifene The metabolism of Raloxifene can be decreased when combined with Indinavir.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Indinavir.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Indinavir.
Efavirenz Efavirenz The serum concentration of Indinavir can be decreased when it is combined with Efavirenz.
Abacavir Abacavir The metabolism of Abacavir can be decreased when combined with Indinavir.
Sildenafil Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Sildenafil.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Indinavir.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Indinavir which could result in a higher serum level.
Rosiglitazone Rosiglitazone Indinavir may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Thalidomide Thalidomide The metabolism of Indinavir can be increased when combined with Thalidomide.
Aluminum Hydroxide Aluminum Hydroxide Aluminum hydroxide can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be decreased when used in combination with Indinavir.
Rabeprazole Rabeprazole Rabeprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Terbinafine Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists